Skip to content

The Effect of Dairy and Non-dairy Alternatives on Satiety and Post-meal Glycemia in Healthy Young Adults

The Effect of Commercially-available Dairy and Non-dairy Alternatives When Consumed With a High Glycemic Cereal on Subjective Appetite Ratings and Post-meal Glycemia in Healthy Young Adults

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02491814
Enrollment
28
Registered
2015-07-08
Start date
2015-01-31
Completion date
2015-06-30
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Obesity

Keywords

Dairy, Breakfast cereal, Postprandial Glycemia, Satiety, Food Intake, Milk, Yogurt, Soy, Almond

Brief summary

This study investigates the effects of commercially-available dairy (1% cow's milk and yogurt beverage) and non-dairy alternatives (almond and soy beverages) on satiety and post-meal blood glucose. Each participant will receive every treatment in this crossover design study.

Detailed description

Regular consumption of dairy is associated with better body composition and lower incidences of type 2 diabetes and obesity. This may be due to dairy's ability to increase satiety and decrease post-prandial glycemia. However, most clinical studies have only investigated isolated dairy proteins (whey and casein) and the effects of whole dairy products remains unclear. Additionally, as non-dairy alternatives are becoming more popular there is interest to see if they can elicit similar benefits as dairy. Therefore, this study will test the effects of commercially-available dairy and non-dairy beverages when consumed with cereal at breakfast time. Thirty healthy young males and females (20-30 years, BMI 20.0-24.9 kg/m2) will be recruited for the randomized, unblinded, crossover study. Participants will fast overnight, and at baseline will consume 250 mL of 1% milk, soy beverage, almond beverage, yogurt beverage, or water with 54 g of Cheerios cereal. At 0 (baseline), 15, 30, 45, 60, 75, 90, 120 minutes (pre-meal period) 140, and 170 minutes (post-meal period) blood will be collected for glucose analysis and subjective appetite ratings completed. Insulin will be analyzed every 30 minutes and for the last two timepoints. Between 120-140 minutes, an ad libitum lunch will be provided to assess food intake.

Interventions

OTHER1% M.F. Milk
OTHERYogurt Beverage
OTHERWater

Sponsors

Dairy Farmers of Canada
CollaboratorOTHER
University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy BMI (20.0 - 24.9 kg/m2) * Females with regular monthly menstrual cycles

Exclusion criteria

* Diabetes * Fasting blood glucose higher than 5.8 mmol/L * Pregnancy * Medications * Smoking * Lactose intolerance or allergies to milk, soy, or almonds * Elite athletes * Those trying to lose or gain weight * Breakfast skippers and those on an energy-restricted diet * Score equal to or higher than 11 on Eating Habits Questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Blood Glucose0-170 minutesBlood glucose (mmol/L) is measured using finger prick capillary blood samples
Subjective Appetite0-170 minutesSubjective appetite ratings are obtained from four 100 mm visual analogue scale (VAS) questions assessing Desire to Eat, Hunger, Fullness and Prospective Food Consumption. The average of all four VAS is calculated to obtain the average appetite score for statistical analysis

Secondary

MeasureTime frameDescription
Insulin0-170 minutesBlood insulin (μU/mL) is measured using finger prick capillary blood samples
Food Intake120-140 minutesFood at an ad libitum pizza lunch will be weighed to determine food intake based on nutrition information provided by the pizza manufacturer

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026